[e-drug] Access to HIV treatment: key data: prices, regulatory status, tariffs, intellectual property situation

E-DRUG: Access to HIV treatment: key data: prices, regulatory status, tariffs, intellectual property situation
-----------------------------------------------------------------------------------------------------------------------

Dear e-druggers,

WHO just published a study on "Increasing access to HIV treatment in
middle-income countries: key data on prices, regulatory status, tariffs and
the intellectual property situation".

The paper provides information on the prices paid by 20 middle-income
countries for adult and paediatric formulations of antiretroviral treatments
recommended by WHO. It links this information with an analysis of the
intellectual property situation of the selected medicines taking into
account existing license agreements as well as compulsory licenses, and
includes data and general information on a number of other determinants of
prices and availability of ARVs, including tariffs, mark ups and taxes, as
well as the regulatory status.

Increasing access to HIV treatment in middle-income countries: key data on
prices, regulatory status, tariffs and the intellectual property situation
http://www.who.int/phi/publications/hiv_increase_access/en/

Regards

Peter Beyer
Public Health, Innovation and Intellectual Property World Health
Organization CH - 1211 Geneva 27
Tel: +41 22 791 2507
beyerp@who.int
http://www.who.int/phi